Company intelligence / Profile preview

Biocan Diagnostics

Coquitlam, British Columbia, Canada
Ownership
Private
Employees
~9
Development stage
Other
01

Overview

Biocan Diagnostics is a Canadian in vitro diagnostics company that develops, manufactures, and distributes rapid and ELISA-based diagnostic tests. The company markets its products under the Tell Me Fast brand and focuses on point-of-care and laboratory testing across infectious diseases, women’s health, cardiac and cancer markers, drugs-of-abuse screening, and food safety. Biocan states that it operates sales, R&D, and manufacturing activities from Coquitlam, British Columbia, and manufactures products in an ISO 13485:2016 MDSAP-certified facility. Its business appears to be primarily commercial rather than therapeutic drug development, with offerings aimed at hospitals, clinics, laboratories, field settings, and home use. The company is healthcare-related, but it is best characterized as an IVD manufacturer rather than a biotech therapeutics developer.

Therapeutic areas
Women's HealthCardiovascularInfectious DiseasesPsychiatryOncology
Modalities
Device
Industry
Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Biocan Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biocan Diagnostics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call